Rubella Antibody (IgG) Immunity
Rubella Antibody (IgG) testing measures Immunoglobulin G antibodies against the rubella virus to determine immune status. Rubella, also known as German measles, is a viral infection that is typically mild in children and adults but can have serious consequences during pregnancy. The presence of rubella IgG antibodies indicates past infection or successful vaccination and therefore immunity to the virus. Establishing immunity is particularly important for women of childbearing age, as rubella infection during early pregnancy can result in Congenital Rubella Syndrome (CRS), a condition associated with miscarriage, hearing impairment, cardiac defects, and developmental abnormalities.
- Price: £79
- Code: RBG
- TAT: 1-2 Working Days
- Sample Type: Blood
Clinical Significance
IgG antibodies develop several weeks after exposure to the virus or vaccination and usually remain detectable for life. A positive IgG result generally indicates protective immunity. A negative result suggests susceptibility to infection and may prompt vaccination if clinically appropriate. Rubella IgG testing is commonly performed as part of pre-conception screening, antenatal care, occupational health assessment for healthcare workers, and immigration medical evaluations. It may also be requested when vaccination history is uncertain. Because rubella can be transmitted through respiratory droplets and may spread before symptoms are apparent, confirming immunity helps protect both individuals and vulnerable populations, particularly pregnant women.
Who Might Benefit From This Test?
This test is particularly important for women planning pregnancy or those in early pregnancy to confirm protective immunity. Healthcare professionals, childcare workers, and individuals with incomplete vaccination records may also benefit from testing. It may also be appropriate for individuals who are unsure whether they received the MMR (Measles, Mumps, Rubella) vaccine or who require documented proof of immunity.
Sample Collection
A blood sample is collected by a trained healthcare professional in a clinical setting. The procedure is quick and minimally invasive. Samples are analysed in laboratories to detect and quantify rubella IgG antibodies.
Understanding Your Results
A positive IgG result indicates immunity to rubella through prior infection or vaccination. A negative result suggests that immunity is not present and vaccination may be recommended where appropriate. Borderline results may require repeat testing. Interpretation is straightforward in most cases, but clinical advice is provided where additional clarification or follow-up is required, particularly in pregnancy planning.
FAQs
When will I receive my results?
Results are usually available within the stated turnaround time.
Should I discuss my results with a doctor?
Yes, results should always be reviewed with a qualified healthcare professional.
Why Choose Marylebone Diagnostic Centre?
Marylebone Diagnostic Centre offers comprehensive infectious disease and immunity screening in a professional and discreet setting. With a turnaround time of 1–2 days, this test provides timely confirmation of rubella immune status for personal, occupational, or pregnancy-related reassurance.
Book Now
Book the Rubella Antibody (IgG) Immunity (RBG) test today to confirm your protection against rubella.
